Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

NCT01700140 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Radiotherapy-induced Nausea and Vomiting (RINV)

Interventions

DRUG: SyB D-0701
DRUG: Placebo

Sponsor

SymBio Pharmaceuticals